Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low glycemic index diet, exercise and vitamin D for prevention of breast cancer recurrence in women
2015-005147-14Phase 3Completed
- Sponsor
- Istituto Nazionale Tumori IRCCS Fondazione Pascale
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cholecalciferol in breast cancer, sponsored by Istituto Nazionale Tumori IRCCS Fondazione Pascale. Primary endpoint: Breast cancer recurrence reduction. Started Oct 2020; status: completed.
02
Drugs
cholecalciferol
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2015-005147-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005147-14.